Non-tuberculous Mycobacteria: Clinical and Laboratory Characterisation (2009 and 2019)
Overview
Public Health
Authors
Affiliations
A cross-sectional and retrospective study of patients with spp. in a Portuguese tertiary hospital, in 2009 and 2019, was performed to understand better the rise in isolations of nontuberculous mycobacteria (NTM). The number of patients with positive samples for spp. grew from 56 in 2009 to 83 in 2019. The proportion of NTM rose from 39.3% to 49.4% ( = 0.240), with being more frequent in 2009 and in 2019, and decreased from 60.7% to 50.6%. Higher age was associated with NTM in both years, and pulmonary disease and immunosuppression were associated with NTM in 2019 ( < 0.05), with weak to moderate correlation ( = 0.231-0.343). The overall rise of NTM, allied to their known capacity to resist antimicrobial therapy, alerts clinicians to the importance of recognising potential risk factors for infection and improving future prevention strategies.
Wang X, Li T, Liu Y, Zhu Y, Chen L, Gao Y Infect Drug Resist. 2024; 17:3989-4000.
PMID: 39296777 PMC: 11410028. DOI: 10.2147/IDR.S475652.